Global Ovarian Cancer Drugs Market Professional Survey Report 2017

October 2017 | 106 pages | ID: GF41BB3B77CPEN
QYResearch

Abstracts

This report studies Ovarian Cancer Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Roche
• Boehringer Ingelheim
• Celgene
• Amgen
• AstraZeneca
• GlaxoSmithKline

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• By Therapy
• Oral Therapy
• Injectable Therapy
• By Drugs
• Cisplatin
• Carboplatin
• Taxol (Paclitaxel)
• Topotecan Hydrochloride
• Gemcitabine Hydrochloride
• Doxorubicin Hydrochloride Liposome
• Other

By Application, the market can be split into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Ovarian Cancer Drugs Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF OVARIAN CANCER DRUGS

1.1 Definition and Specifications of Ovarian Cancer Drugs
  1.1.1 Definition of Ovarian Cancer Drugs
  1.1.2 Specifications of Ovarian Cancer Drugs
1.2 Classification of Ovarian Cancer Drugs
  1.2.1 Oral Therapy
  1.2.2 Injectable Therapy
1.3 Applications of Ovarian Cancer Drugs
  1.3.1 Chemotherapy
  1.3.2 Targeted Therapy
  1.3.3 Immunotherapy (Biologic Therapy)
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF OVARIAN CANCER DRUGS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ovarian Cancer Drugs
2.3 Manufacturing Process Analysis of Ovarian Cancer Drugs
2.4 Industry Chain Structure of Ovarian Cancer Drugs

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF OVARIAN CANCER DRUGS

3.1 Capacity and Commercial Production Date of Global Ovarian Cancer Drugs Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Ovarian Cancer Drugs Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Ovarian Cancer Drugs Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Ovarian Cancer Drugs Major Manufacturers in 2016

4 GLOBAL OVARIAN CANCER DRUGS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Ovarian Cancer Drugs Capacity and Growth Rate Analysis
  4.2.2 2016 Ovarian Cancer Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Ovarian Cancer Drugs Sales and Growth Rate Analysis
  4.3.2 2016 Ovarian Cancer Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Ovarian Cancer Drugs Sales Price
  4.4.2 2016 Ovarian Cancer Drugs Sales Price Analysis (Company Segment)

5 OVARIAN CANCER DRUGS REGIONAL MARKET ANALYSIS

5.1 North America Ovarian Cancer Drugs Market Analysis
  5.1.1 North America Ovarian Cancer Drugs Market Overview
  5.1.2 North America 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.1.4 North America 2016 Ovarian Cancer Drugs Market Share Analysis
5.2 China Ovarian Cancer Drugs Market Analysis
  5.2.1 China Ovarian Cancer Drugs Market Overview
  5.2.2 China 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.2.4 China 2016 Ovarian Cancer Drugs Market Share Analysis
5.3 Europe Ovarian Cancer Drugs Market Analysis
  5.3.1 Europe Ovarian Cancer Drugs Market Overview
  5.3.2 Europe 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.3.4 Europe 2016 Ovarian Cancer Drugs Market Share Analysis
5.4 Southeast Asia Ovarian Cancer Drugs Market Analysis
  5.4.1 Southeast Asia Ovarian Cancer Drugs Market Overview
  5.4.2 Southeast Asia 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.4.4 Southeast Asia 2016 Ovarian Cancer Drugs Market Share Analysis
5.5 Japan Ovarian Cancer Drugs Market Analysis
  5.5.1 Japan Ovarian Cancer Drugs Market Overview
  5.5.2 Japan 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.5.4 Japan 2016 Ovarian Cancer Drugs Market Share Analysis
5.6 India Ovarian Cancer Drugs Market Analysis
  5.6.1 India Ovarian Cancer Drugs Market Overview
  5.6.2 India 2012-2017E Ovarian Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Ovarian Cancer Drugs Sales Price Analysis
  5.6.4 India 2016 Ovarian Cancer Drugs Market Share Analysis

6 GLOBAL 2012-2017E OVARIAN CANCER DRUGS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Ovarian Cancer Drugs Sales by Type
6.2 Different Types of Ovarian Cancer Drugs Product Interview Price Analysis
6.3 Different Types of Ovarian Cancer Drugs Product Driving Factors Analysis
  6.3.1 By Therapy of Ovarian Cancer Drugs Growth Driving Factor Analysis
  6.3.2 By Drugs of Ovarian Cancer Drugs Growth Driving Factor Analysis

7 GLOBAL 2012-2017E OVARIAN CANCER DRUGS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Ovarian Cancer Drugs Consumption by Application
7.2 Different Application of Ovarian Cancer Drugs Product Interview Price Analysis
7.3 Different Application of Ovarian Cancer Drugs Product Driving Factors Analysis
  7.3.1 Chemotherapy of Ovarian Cancer Drugs Growth Driving Factor Analysis
  7.3.2 Targeted Therapy of Ovarian Cancer Drugs Growth Driving Factor Analysis
  7.3.3 Immunotherapy (Biologic Therapy) of Ovarian Cancer Drugs Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF OVARIAN CANCER DRUGS

8.1 Roche
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Roche 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Roche 2016 Ovarian Cancer Drugs Business Region Distribution Analysis
8.2 Boehringer Ingelheim
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Boehringer Ingelheim 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Boehringer Ingelheim 2016 Ovarian Cancer Drugs Business Region Distribution Analysis
8.3 Celgene
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Celgene 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Celgene 2016 Ovarian Cancer Drugs Business Region Distribution Analysis
8.4 Amgen
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Amgen 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Amgen 2016 Ovarian Cancer Drugs Business Region Distribution Analysis
8.5 AstraZeneca
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 AstraZeneca 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 AstraZeneca 2016 Ovarian Cancer Drugs Business Region Distribution Analysis
8.6 GlaxoSmithKline
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 GlaxoSmithKline 2016 Ovarian Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 GlaxoSmithKline 2016 Ovarian Cancer Drugs Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF OVARIAN CANCER DRUGS MARKET

9.1 Global Ovarian Cancer Drugs Market Trend Analysis
  9.1.1 Global 2017-2022 Ovarian Cancer Drugs Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Ovarian Cancer Drugs Sales Price Forecast
9.2 Ovarian Cancer Drugs Regional Market Trend
  9.2.1 North America 2017-2022 Ovarian Cancer Drugs Consumption Forecast
  9.2.2 China 2017-2022 Ovarian Cancer Drugs Consumption Forecast
  9.2.3 Europe 2017-2022 Ovarian Cancer Drugs Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Ovarian Cancer Drugs Consumption Forecast
  9.2.5 Japan 2017-2022 Ovarian Cancer Drugs Consumption Forecast
  9.2.6 India 2017-2022 Ovarian Cancer Drugs Consumption Forecast
9.3 Ovarian Cancer Drugs Market Trend (Product Type)
9.4 Ovarian Cancer Drugs Market Trend (Application)

10 OVARIAN CANCER DRUGS MARKETING TYPE ANALYSIS

10.1 Ovarian Cancer Drugs Regional Marketing Type Analysis
10.2 Ovarian Cancer Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Ovarian Cancer Drugs by Region
10.4 Ovarian Cancer Drugs Supply Chain Analysis

11 CONSUMERS ANALYSIS OF OVARIAN CANCER DRUGS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL OVARIAN CANCER DRUGS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ovarian Cancer Drugs
Table Product Specifications of Ovarian Cancer Drugs
Table Classification of Ovarian Cancer Drugs
Figure Global Production Market Share of Ovarian Cancer Drugs by Type in 2016
Figure Oral Therapy Picture
Table Major Manufacturers of Oral Therapy
Figure Injectable Therapy Picture
Table Major Manufacturers of Injectable Therapy
Table Applications of Ovarian Cancer Drugs
Figure Global Consumption Volume Market Share of Ovarian Cancer Drugs by Application in 2016
Figure Chemotherapy Examples
Table Major Consumers in Chemotherapy
Figure Targeted Therapy Examples
Table Major Consumers in Targeted Therapy
Figure Immunotherapy (Biologic Therapy) Examples
Table Major Consumers in Immunotherapy (Biologic Therapy)
Figure Market Share of Ovarian Cancer Drugs by Regions
Figure North America Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Figure China Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Europe Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Southeast Asia Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Figure Japan Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Figure India Ovarian Cancer Drugs Market Size (Million USD) (2012-2022)
Table Ovarian Cancer Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ovarian Cancer Drugs in 2016
Figure Manufacturing Process Analysis of Ovarian Cancer Drugs
Figure Industry Chain Structure of Ovarian Cancer Drugs
Table Capacity and Commercial Production Date of Global Ovarian Cancer Drugs Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Ovarian Cancer Drugs Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Ovarian Cancer Drugs Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Ovarian Cancer Drugs Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Ovarian Cancer Drugs 2012-2017
Figure Global 2012-2017E Ovarian Cancer Drugs Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Ovarian Cancer Drugs Market Size (Value) and Growth Rate
Table 2012-2017E Global Ovarian Cancer Drugs Capacity and Growth Rate
Table 2016 Global Ovarian Cancer Drugs Capacity (MT) List (Company Segment)
Table 2012-2017E Global Ovarian Cancer Drugs Sales (MT) and Growth Rate
Table 2016 Global Ovarian Cancer Drugs Sales (MT) List (Company Segment)
Table 2012-2017E Global Ovarian Cancer Drugs Sales Price (K USD/Kg)
Table 2016 Global Ovarian Cancer Drugs Sales Price (K USD/Kg) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure North America 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure North America 2016 Ovarian Cancer Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure China 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure China 2016 Ovarian Cancer Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure Europe 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure Europe 2016 Ovarian Cancer Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure Southeast Asia 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure Southeast Asia 2016 Ovarian Cancer Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure Japan 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure Japan 2016 Ovarian Cancer Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (MT) of Ovarian Cancer Drugs 2012-2017E
Figure India 2012-2017E Ovarian Cancer Drugs Sales Price (K USD/Kg)
Figure India 2016 Ovarian Cancer Drugs Sales Market Share
Table Global 2012-2017E Ovarian Cancer Drugs Sales (MT) by Type
Table Different Types Ovarian Cancer Drugs Product Interview Price
Table Global 2012-2017E Ovarian Cancer Drugs Sales (MT) by Application
Table Different Application Ovarian Cancer Drugs Product Interview Price
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2016 Roche Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 Roche Ovarian Cancer Drugs Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 Boehringer Ingelheim Ovarian Cancer Drugs Business Region Distribution
Table Celgene Information List
Table Product A Overview
Table Product B Overview
Table 2015 Celgene Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 Celgene Ovarian Cancer Drugs Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 Amgen Ovarian Cancer Drugs Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 AstraZeneca Ovarian Cancer Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Ovarian Cancer Drugs Revenue (Million USD), Sales (MT), Ex-factory Price (K USD/Kg)
Figure 2016 GlaxoSmithKline Ovarian Cancer Drugs Business Region Distribution
Figure Global 2017-2022 Ovarian Cancer Drugs Market Size (MT) and Growth Rate Forecast
Figure Global 2017-2022 Ovarian Cancer Drugs Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Ovarian Cancer Drugs Sales Price (K USD/Kg) Forecast
Figure North America 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Figure China 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Figure Europe 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Figure Japan 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Figure India 2017-2022 Ovarian Cancer Drugs Consumption Volume (MT) and Growth Rate Forecast
Table Global Sales Volume (MT) of Ovarian Cancer Drugs by Type 2017-2022
Table Global Consumption Volume (MT) of Ovarian Cancer Drugs by Application 2017-2022
Table Traders or Distributors with Contact Information of Ovarian Cancer Drugs by Region